paclitaxel has been researched along with EBV Infections in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Chen, M; Wu, J; Ye, Z | 1 |
Furuya, T; Hayashi, H; Murakami, T; Shimokawa, Y; Sugihara, S; Yahara, N; Yanai, H | 1 |
Busson, P; Feng, WH; Israel, B; Kenney, SC; Raab-Traub, N | 1 |
1 review(s) available for paclitaxel and EBV Infections
Article | Year |
---|---|
Is the interstitial lung disease induced by trastuzumab? Case report and literature review.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Breast Neoplasms; Epstein-Barr Virus Infections; Female; Ganciclovir; Humans; Lung Diseases, Interstitial; Paclitaxel; Trastuzumab | 2020 |
2 other study(ies) available for paclitaxel and EBV Infections
Article | Year |
---|---|
Long-Term Survival of Patient with Epstein-Barr Virus-Positive Gastric Cancer Treated with Chemotherapy: Case Report.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Epstein-Barr Virus Infections; Female; Fluorouracil; Follow-Up Studies; Herpesvirus 4, Human; Humans; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Paclitaxel; Prognosis; Stomach Neoplasms; Survival Rate; Tegafur; Time Factors | 2016 |
Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carcinoma; Cisplatin; Drug Synergism; Epithelial Cells; Epstein-Barr Virus Infections; Female; Fluorouracil; Ganciclovir; Herpesvirus 4, Human; Humans; MAP Kinase Signaling System; Mice; Mice, Nude; Paclitaxel; Stomach Neoplasms; Virus Replication; Xenograft Model Antitumor Assays | 2002 |